{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:43:50Z","timestamp":1787003030047,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1038\/s41440-019-0258-y","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T03:02:59Z","timestamp":1554692579000},"page":"1152-1161","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Cucurbitacins extracted from Cucumis melo L. (CuEC) exert a hypotensive effect via regulating vascular tone"],"prefix":"10.1038","volume":"42","author":[{"given":"Ru-Qiang","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jing","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hui","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Xin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Qi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ri-Chang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"key":"258_CR1","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1179\/2295333714Y.0000000069","volume":"69","author":"G Camp Van","year":"2014","unstructured":"Van Camp G. Cardiovascular disease prevention. Acta Clin Belg. 2014;69:407\u201311.","journal-title":"Acta Clin Belg"},{"key":"258_CR2","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0140-6736(14)61468-9","volume":"386","author":"NR Poulter","year":"2015","unstructured":"Poulter NR, Prabhakaran D, Caulfield M. Hypertension. Lancet (Lond, Engl). 2015;386:801\u201312.","journal-title":"Lancet (Lond, Engl)"},{"key":"258_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-015-0596-3","volume":"17","author":"E Gkaliagkousi","year":"2015","unstructured":"Gkaliagkousi E, Gavriilaki E, Triantafyllou A, Douma S. Clinical significance of endothelial dysfunction in essential hypertension. Curr Hypertens Rep. 2015;17:85.","journal-title":"Curr Hypertens Rep"},{"key":"258_CR4","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1159\/000355270","volume":"50","author":"MA Boegehold","year":"2013","unstructured":"Boegehold MA. The effect of high salt intake on endothelial function: Reduced vascular nitric oxide in the absence of hypertension. J Vasc Res. 2013;50:458\u201367.","journal-title":"J Vasc Res"},{"key":"258_CR5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.arr.2014.10.001","volume":"18","author":"ME Rubio-Ruiz","year":"2014","unstructured":"Rubio-Ruiz ME, Perez-Torres I, Soto ME, Pastelin G, Guarner-Lans V. Aging in blood vessels. Medicinal agents for systemic arterial hypertension in the elderly. Ageing Res Rev. 2014;18:132\u201347.","journal-title":"Ageing Res Rev"},{"key":"258_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1517\/17425250903397381","volume":"6","author":"C Hocht","year":"2010","unstructured":"Hocht C, Bertera FM, Mayer MA, Taira CA. Issues in drug metabolism of major antihypertensive drugs: Beta-blockers, calcium channel antagonists and angiotensin receptor blockers. Expert Opin drug Metab Toxicol. 2010;6:199\u2013211.","journal-title":"Expert Opin drug Metab Toxicol"},{"key":"258_CR7","first-page":"Cd001841","volume":"4","author":"JM Wright","year":"2018","unstructured":"Wright JM, Musini VM, Gill R. First-line drugs for hypertension. Cochrane database Syst Rev. 2018;4:Cd001841.","journal-title":"Cochrane database Syst Rev"},{"key":"258_CR8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.phrs.2017.07.026","volume":"124","author":"S Laurent","year":"2017","unstructured":"Laurent S. Antihypertensive drugs. Pharmacol Res. 2017;124:116\u201325.","journal-title":"Pharmacol Res"},{"key":"258_CR9","first-page":"Cd002003","volume":"1","author":"CS Wiysonge","year":"2017","unstructured":"Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Opie LH. Beta-blockers for hypertension. Cochrane database Syst Rev. 2017;1:Cd002003.","journal-title":"Cochrane database Syst Rev"},{"key":"258_CR10","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1093\/ajh\/hpw030","volume":"29","author":"GC Roush","year":"2016","unstructured":"Roush GC, Sica DA. Diuretics for hypertension: a review and update. Am J Hypertens. 2016;29:1130\u20137.","journal-title":"Am J Hypertens"},{"key":"258_CR11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/HCO.0000000000000189","volume":"30","author":"SG Chrysant","year":"2015","unstructured":"Chrysant SG. Antihypertensive therapy causes erectile dysfunction. Curr Opin Cardiol. 2015;30:383\u201390.","journal-title":"Curr Opin Cardiol"},{"key":"258_CR12","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1097\/HJH.0000000000000447","volume":"33","author":"C Thomopoulos","year":"2015","unstructured":"Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure-lowering on outcome incidence in hypertension: 5. Head-to-head comparisons of various classes of antihypertensive drugs - overview and meta-analyses. J Hypertens. 2015;33:1321\u201341.","journal-title":"J Hypertens"},{"key":"258_CR13","unstructured":"Na L, Ang G, Jiang G, Lei D, Xu J, Hui Z, et al. Research advance on pharmaceutical science of melon pedicle. J Anhui Agric Sci. 2011;39:8369\u201370."},{"key":"258_CR14","unstructured":"Liu X, Fu Y. Clinical application of melon pedicle and understanding of poisoning. Gansu J Tradit Chin Med. 2008;21:7\u20139."},{"key":"258_CR15","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1142\/S0192415X15500755","volume":"43","author":"Y Cai","year":"2015","unstructured":"Cai Y, Fang X, He C, Li P, Xiao F, Wang Y et al. Cucurbitacins: a systematic review of the phytochemistry and anticancer activity. Am J Chin Med. 2015;43:1331\u201350.","journal-title":"Am J Chin Med"},{"key":"258_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4103\/0973-7847.156314","volume":"9","author":"U Kaushik","year":"2015","unstructured":"Kaushik U, Aeri V, Mir SR. Cucurbitacins - an insight into medicinal leads from nature. Pharmacogn Rev. 2015;9:12\u201318.","journal-title":"Pharmacogn Rev"},{"key":"258_CR17","first-page":"351","volume":"31","author":"W Chen","year":"2014","unstructured":"Chen W, Sun Y, Yuan Z, Li Y, Wang L, Wu L. Isolation and identification of the chemical constituents of pedicellus melo. J Shenyang Pharm Univ. 2014;31:351\u20134.","journal-title":"J Shenyang Pharm Univ"},{"key":"258_CR18","unstructured":"Lan T, Ya Z, Hai-feng S, Weiguang S. Studies on the separation of cucurbitacins from the fruit base of cucumis melo l. And their antitumor activities. J Zhejiang Univ Technol. 2012;449:388\u2013391."},{"key":"258_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ejphar.2015.10.003","volume":"768","author":"Y Sun","year":"2015","unstructured":"Sun Y, Zhang J, Zhou J, Huang Z, Hu H, Qiao M et al. Synergistic effect of cucurbitacin b in combination with curcumin via enhancing apoptosis induction and reversing multidrug resistance in human hepatoma cells. Eur J Pharmacol. 2015;768:28\u201340.","journal-title":"Eur J Pharmacol"},{"key":"258_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3892\/mmr.2014.2175","volume":"10","author":"Q Zheng","year":"2014","unstructured":"Zheng Q, Liu Y, Liu W, Ma F, Zhou Y, Chen M et al. Cucurbitacin b inhibits growth and induces apoptosis through the jak2\/stat3 and mapk pathways in shsy5y human neuroblastoma cells. Mol Med Rep. 2014;10:89\u201394.","journal-title":"Mol Med Rep"},{"key":"258_CR21","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1159\/000338757","volume":"89","author":"JS Zhu","year":"2012","unstructured":"Zhu JS, Ouyang DY, Shi ZJ, Xu LH, Zhang YT, He XH. Cucurbitacin b induces cell cycle arrest, apoptosis and autophagy associated with g actin reduction and persistent activation of cofilin in jurkat cells. Pharmacology. 2012;89:348\u2013346.","journal-title":"Pharmacology"},{"key":"258_CR22","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1111\/j.1476-5381.2010.00741.x","volume":"160","author":"GB Iwanski","year":"2010","unstructured":"Iwanski GB, Lee DH, En-Gal S, Doan NB, Castor B, Vogt M et al. Cucurbitacin b, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer. Br J Pharmacol. 2010;160:998\u20131007.","journal-title":"Br J Pharmacol"},{"key":"258_CR23","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1158\/1940-6207.CAPR-14-0286","volume":"8","author":"S Shukla","year":"2015","unstructured":"Shukla S, Khan S, Kumar S, Sinha S, Farhan M, Bora HK et al. Cucurbitacin b alters the expression of tumor-related genes by epigenetic modifications in nsclc and inhibits nnk-induced lung tumorigenesis. Cancer Prev Res (Phila, Pa). 2015;8:552\u201362.","journal-title":"Cancer Prev Res (Phila, Pa)"},{"key":"258_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/srep21860","volume":"6","author":"S Shukla","year":"2016","unstructured":"Shukla S, Sinha S, Khan S, Kumar S, Singh K, Mitra K et al. Cucurbitacin b inhibits the stemness and metastatic abilities of nsclc via downregulation of canonical wnt\/beta-catenin signaling axis. Sci Rep. 2016;6:21860.","journal-title":"Sci Rep"},{"key":"258_CR25","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.3892\/etm.2016.3670","volume":"12","author":"YL Xie","year":"2016","unstructured":"Xie YL, Tao WH, Yang TX, Qiao JG. Anticancer effect of cucurbitacin b on mkn-45 cells via inhibition of the jak2\/stat3 signaling pathway. Exp Ther Med. 2016;12:2709\u201315.","journal-title":"Exp Ther Med"},{"key":"258_CR26","doi-asserted-by":"publisher","first-page":"e55732","DOI":"10.1371\/journal.pone.0055732","volume":"8","author":"M Promkan","year":"2013","unstructured":"Promkan M, Dakeng S, Chakrabarty S, Bogler O, Patmasiriwat P. The effectiveness of cucurbitacin b in brca1 defective breast cancer cells. PloS ONE. 2013;8:e55732.","journal-title":"PloS ONE"},{"key":"258_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/srep36594","volume":"6","author":"M Sikander","year":"2016","unstructured":"Sikander M, Hafeez BB, Malik S, Alsayari A, Halaweish FT, Yallapu MM et al. Cucurbitacin d exhibits potent anti-cancer activity in cervical cancer. Sci Rep. 2016;6:36594.","journal-title":"Sci Rep"},{"key":"258_CR28","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1021\/acs.jnatprod.5b00054","volume":"78","author":"JA Hall","year":"2015","unstructured":"Hall JA, Seedarala S, Rice N, Kopel L, Halaweish F, Blagg BS. Cucurbitacin d is a disruptor of the hsp90 chaperone machinery. J Nat Prod. 2015;78:873\u20139.","journal-title":"J Nat Prod"},{"key":"258_CR29","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1093\/carcin\/bgq167","volume":"31","author":"Y Dong","year":"2010","unstructured":"Dong Y, Lu B, Zhang X, Zhang J, Lai L, Li D et al. Cucurbitacin e, a tetracyclic triterpenes compound from chinese medicine, inhibits tumor angiogenesis through vegfr2-mediated jak2-stat3 signaling pathway. Carcinogenesis. 2010;31:2097\u2013104.","journal-title":"Carcinogenesis"},{"key":"258_CR30","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.2174\/1568026615666150427121331","volume":"15","author":"E Attard","year":"2015","unstructured":"Attard E, Martinoli MG. Cucurbitacin e, an experimental lead triterpenoid with anticancer, immunomodulatory and novel effects against degenerative diseases. A mini-review. Curr Top Med Chem. 2015;15:1708\u201313.","journal-title":"Curr Top Med Chem"},{"key":"258_CR31","doi-asserted-by":"publisher","first-page":"e0124355","DOI":"10.1371\/journal.pone.0124355","volume":"10","author":"QB Zha","year":"2015","unstructured":"Zha QB, Zhang XY, Lin QR, Xu LH, Zhao GX, Pan H et al. Cucurbitacin e induces autophagy via downregulating mtorc1 signaling and upregulating ampk activity. PloS ONE. 2015;10:e0124355.","journal-title":"PloS ONE"},{"key":"258_CR32","first-page":"8159261","volume":"2018","author":"D Lee","year":"2018","unstructured":"Lee D, Yoo JH, Lee BC. Therapeutic effect of cucumis melo l. Extract on insulin resistance and the gut microbiome in lep(ob)\/lep(ob) mice. Evid Based Complement Altern Med. 2018;2018:8159261.","journal-title":"Evid Based Complement Altern Med"},{"key":"258_CR33","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3389\/fphar.2018.01071","volume":"9","author":"KH Kim","year":"2018","unstructured":"Kim KH, Lee IS, Park JY, Kim Y, An EJ, Jang HJ. Cucurbitacin b induces hypoglycemic effect in diabetic mice by regulation of amp-activated protein kinase alpha and glucagon-like peptide-1 via bitter taste receptor signaling. Front Pharmacol. 2018;9:1071.","journal-title":"Front Pharmacol"},{"key":"258_CR34","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/cbdd.13160","volume":"91","author":"AM Sallam","year":"2018","unstructured":"Sallam AM, Esmat A, Abdel-Naim AB. Cucurbitacin-b attenuates ccl4 -induced hepatic fibrosis in mice through inhibition of stat-3. Chem Biol Drug Des. 2018;91:933\u201341.","journal-title":"Chem Biol Drug Des"},{"key":"258_CR35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.toxlet.2016.06.2102","volume":"258","author":"YL Wu","year":"2016","unstructured":"Wu YL, Zhang YJ, Yao YL, Li ZM, Han X, Lian LH et al. Cucurbitacin e ameliorates hepatic fibrosis in vivo and in vitro through activation of ampk and blocking mtor-dependent signaling pathway. Toxicol Lett. 2016;258:147\u201358.","journal-title":"Toxicol Lett"},{"key":"258_CR36","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1002\/jcb.26041","volume":"118","author":"Y Xiao","year":"2017","unstructured":"Xiao Y, Yang Z, Wu QQ, Jiang XH, Yuan Y, Chang W et al. Cucurbitacin b protects against pressure overload induced cardiac hypertrophy. J Cell Biochem. 2017;118:3899\u2013910.","journal-title":"J Cell Biochem"},{"key":"258_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/srep40237","volume":"7","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Jiang M, Xie X, Yang H, Wang X, Xiao L et al. Oleanolic acid ameliorates high glucose-induced endothelial dysfunction via ppardelta activation. Sci Rep. 2017;7:40237.","journal-title":"Sci Rep"},{"key":"258_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/157016112798829760","volume":"10","author":"D Tousoulis","year":"2012","unstructured":"Tousoulis D, Kampoli AM, Tentolouris C, Papageorgiou N, Stefanadis C. The role of nitric oxide on endothelial function. Curr Vasc Pharmacol. 2012;10:4\u201318.","journal-title":"Curr Vasc Pharmacol"},{"key":"258_CR39","first-page":"13","volume":"18","author":"J Hong","year":"1996","unstructured":"Hong J. Cucurbitacins and its pharmacological studies. Foreign Med Sci. 1996;18:13\u201314.","journal-title":"Foreign Med Sci"},{"key":"258_CR40","first-page":"251","volume":"1","author":"AM Kamper","year":"2005","unstructured":"Kamper AM, de Craen AJ, Westendorp RG, Blauw GJ. Endothelium-dependent no-mediated vasodilation in humans is attenuated by peripheral alpa1-adrenoceptor activation. Vasc health risk Manag. 2005;1:251\u20136.","journal-title":"Vasc health risk Manag"},{"key":"258_CR41","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/micc.12046","volume":"20","author":"GC Amberg","year":"2013","unstructured":"Amberg GC, Navedo MF. Calcium dynamics in vascular smooth muscle. Microcirculation . 2013;20:281\u20139.","journal-title":"Microcirculation"},{"key":"258_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/01.hjh.0000194119.42722.21","volume":"24","author":"G Mancia","year":"2006","unstructured":"Mancia G, Grassi G, Zanchetti A. New-onset diabetes and anti hypertensive drugs. J Hypertens. 2006;24:3\u201310.","journal-title":"J Hypertens"},{"key":"258_CR43","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/HJH.0b013e32831e13e5","volume":"27","author":"J Redon","year":"2009","unstructured":"Redon J, Cifkova R, Laurent S, Nilsson P, Narkiewicz K, Erdine S et al. Mechanisms of hypertension in the cardiometabolic syndrome. J Hypertens. 2009;27:441\u201351.","journal-title":"J Hypertens"},{"key":"258_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4254\/wjh.v6.i1.41","volume":"6","author":"YM Fouad","year":"2014","unstructured":"Fouad YM, Yehia R. Hepato-cardiac disorders. World J Hepatol. 2014;6:41\u201354.","journal-title":"World J Hepatol"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41440-019-0258-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-019-0258-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-019-0258-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:20:37Z","timestamp":1684603237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-019-0258-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["258"],"URL":"https:\/\/doi.org\/10.1038\/s41440-019-0258-y","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,8]]},"assertion":[{"value":"30 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}